Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Citius Pharmaceuticals, Inc.
NASDAQ:CTXRHealthcare · Biotechnology
-7.10%$0.5231
AH$0.5300+1.32%vs close
Mkt Cap$14.36M
Float26.86M
O/S27.45M
Vol
$ Vol
RVOL
Inst Own5.0%
SI21.2%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$37.43M
Total Assets$130.94M
Free Cash Flow-$26.55M
Debt & Equity
Debt 3%
Equity 97%
Total Debt$1.81M
Total Equity$67.55M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:25
Nasdaq bars a compliance period at 1:250
- 1:25Reverse splitNov 26, 202425 shares → 1
- 1:15Reverse splitJun 9, 201715 shares → 1
Balance Sheet Details
Assets$130.94M
Liabilities$53.41M
Accounts Receivable$0
Accounts Payable$13.69M
Inventory$22.29M
PP&E (Net)$819K
Goodwill$9.35M
Intangible Assets$92.8M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $214K | $210K | $0 | $0 | $165K | $152K | $893 | $2K | $3K | $1K | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$214K | -$210K | $0 | $0 | -$165K | -$152K | -$893 | -$2K | -$3K | -$1K | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $9.16M | $11.91M | $14.82M | $17.66M | $12.24M | $8.81M | $8.6M | $6.56M | $2.94M | $2.93M | $1.8M | $438K | $492K | $706 | $0 |
| Selling, General, and Administrative | $18.53M | $18.25M | $21.91M | $15.66M | $11.13M | $8.75M | $7M | $7.23M | $7.05M | $4.52M | $1.43M | $715K | $28K | $20K | $26K |
| Other | $10.62M | $11.84M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $38.31M | $42M | $36.73M | $33.32M | $23.37M | $17.56M | $15.6M | $13.79M | $9.99M | $7.45M | $3.23M | $1.14M | $28K | $20K | $26K |
| Operating Income (EBIT) | -$38.53M | -$42M | -$36.73M | -$33.32M | -$23.53M | -$17.71M | -$15.6M | -$13.79M | -$9.99M | -$7.45M | -$3.23M | -$1.15M | -$28K | -$20K | -$26K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $268K | $0 | $0 | $0 | $11K | $16K | $16K | $16K | $851K | $9K | $8K | $0 | $3K | $2K | $0 |
| Interest Income | $110K | $758K | $1.18M | $251K | $262K | $68K | $53K | $0 | $806 | $806 | $3K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$158K | $3.15M | $4.77M | $251K | $477K | $163K | $36K | $1.25M | -$399K | -$846K | $328K | $172K | $0 | -$2K | -$704 |
| Income Before Tax (EBT) | -$38.68M | -$38.85M | -$31.97M | -$33.06M | -$23.05M | -$17.55M | -$15.56M | -$12.54M | -$10.38M | -$8.3M | -$2.9M | -$1.27M | -$31K | -$22K | -$26K |
| Income Tax Expense | $1.06M | $576K | $576K | $576K | $0 | $0 | $16K | $0 | $0 | $9K | $4K | -$119K | -$1.18M | $0 | $0 |
| Net Income | -$37.43M | -$39.14M | -$32.54M | -$33.64M | -$23.05M | -$17.55M | -$15.58M | -$12.54M | -$10.38M | -$8.3M | -$2.9M | -$1.27M | -$31K | -$22K | -$26K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||||||
| EPS | -3.38 | -5.97 | -5.57 | -5.75 | -5.64 | -11.20 | -0.77 | -1.17 | -1.89 | -2.29 | -1.37 | -0.95 | -0.04 | -0.03 | -0.04 |
| Diluted EPS | -3.38 | -5.97 | -5.57 | -5.75 | -5.64 | -11.20 | -0.77 | -1.17 | -1.89 | -2.29 | -1.37 | -0.95 | -0.04 | -0.03 | -0.04 |
| Weighted Average OS | 11.07M | 11.59M | 6.05M | 5.84M | 4.34M | 1.57M | 1.34M | 715,458 | 365,500 | 241,547 | 141,491 | 89,351 | 50,000 | 50,000 | 50,000 |
| EBITDA | -$38.2M | -$38.64M | -$36.54M | -$33.14M | -$23.37M | -$17.56M | -$15.54M | -$13.79M | -$9.98M | -$7.45M | $335K | $0 | -$1.15M | $1K | -$25K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.2M | $294K | $676K | $1.55M | $54K | $135 | $212 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.2M | $294K | $676K | $1.55M | $54K | $135 | $212 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $818K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $22.29M | $8.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $39K | $0 | $0 |
| Total Current Assets | $27.93M | $14.22M | $34.37M | $44.56M | $72.81M | $13.98M | $7.94M | $10.06M | $3.42M | $893K | $736K | $1.55M | $103K | $135 | $212 |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $819K | $246K | $456K | $650K | $830K | $988K | $590 | $1K | $3K | $4K | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $1.59M | $1.59M | $1.59M | $1.59M | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $92.8M | $92.8M | $59.4M | $59.4M | $59.4M | $19.4M | $19.4M | $19.4M | $19.4M | $19.4M | $5K | $5K | $5K | $5 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $16.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | -$16.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $38K | $38K | $38K | $38K | $38K | $57K | $57K | $2K | $2K | $67K | $0 | $0 | $0 | -$5 | $0 |
| Total Long-Term Assets | $103M | $102.43M | $69.24M | $69.44M | $69.61M | $29.79M | $21.04M | $20.99M | $20.99M | $21.06M | $5K | $5K | $5K | $5 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $1 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5 | $0 |
| Total Assets | $130.94M | $116.65M | $103.61M | $114M | $142.43M | $43.77M | $28.99M | $31.05M | $24.42M | $21.95M | $742K | $1.56M | $108K | $135 | $212 |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $13.69M | $4.93M | $2.93M | $1.17M | $1.28M | $1.86M | $2.71M | $1.57M | $602K | $909K | $559K | $106K | $11K | $0 | $906 |
| Short-Term Debt | $1M | $0 | $0 | $0 | $177K | $173K | $173K | $173K | $173K | $673K | $0 | $600K | $3K | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.92M | $0 | $142K | $0 | -$97 | $0 |
| Other Current Liabilities | $3.29M | $2.23M | $2.16M | $1.76M | $622K | $1.65M | $321K | $0 | $0 | $2.67M | $809K | $1.51M | $0 | $17 | $0 |
| Total Current Liabilities | $44.91M | $35.81M | $5.78M | $4.53M | $3.98M | $4.1M | $4.61M | $3.18M | $2.47M | $5.18M | $1.38M | $2.3M | $15K | $46 | $24 |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $165K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $165 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $7.77M | $6.71M | $6.14M | $5.56M | $4.99M | $4.99M | $4.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $8.5M | $6.74M | $6.4M | $6.04M | $5.66M | $6.01M | $4.99M | $1.75M | $0 | $0 | $0 | $0 | $1.69M | $1K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$4.99M | -$1.75M | $0 | $0 | $0 | $0 | -$1.69M | -$1K | $0 |
| Total Liabilities | $53.41M | $42.55M | $12.18M | $10.57M | $9.65M | $10.1M | $4.61M | $3.18M | $2.47M | $5.18M | $1.38M | $2.3M | $15K | $46K | $24K |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $18K | $7K | $6K | $146K | $146K | $56K | $29K | $16K | $8K | $73K | $34K | $30K | $18K | $18K | $18K |
| Retained Earnings | -$238.8M | -$201.37M | -$162.23M | -$129.69M | -$96.05M | -$70.59M | -$55.82M | -$40.26M | -$27.72M | -$17.34M | -$9.04M | -$6.14M | -$95K | -$64K | -$42K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $306.34M | $271.44M | $253.06M | $232.37M | $228.08M | $104.21M | $80.17M | $68.11M | $49.66M | $34.03M | $8.37M | $5.37M | $63K | $0 | $0 |
| Total Equity | $67.55M | $70.08M | $90.83M | $102.83M | $132.18M | $33.67M | $24.38M | $27.87M | $21.95M | $16.77M | -$635K | -$742K | -$15K | -$46K | -$24K |
| Minority Interest | $9.98M | $4.02M | $600K | $600K | $600K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $120.96M | $112.63M | $103.01M | $113.4M | $141.83M | $43.77M | $28.99M | $31.05M | $24.42M | $21.95M | $742K | $1.56M | $0 | $135 | $212 |
| Supplementary Data | |||||||||||||||
| Total Debt | $1.81M | $263K | $481K | $678K | $855K | $1.35M | $173K | $173K | $173K | $673K | $0 | $600K | $3K | $17K | $18K |
| Net Debt | -$2.44M | -$2.99M | -$26M | -$41.03M | -$69.22M | -$12.51M | -$7.72M | -$9.01M | -$3.03M | $379K | -$676K | -$952K | -$51K | $17 | $18K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 |
| Operating Activities | |||||||||||||||
| Net Income | -$39.74M | -$39.43M | -$32.54M | -$33.64M | -$23.05M | -$17.55M | -$15.56M | -$12.54M | -$10.38M | -$8.3M | -$2.9M | -$1.27M | -$31K | -$22K | -$26K |
| Depreciation & Amortization | $214K | $210K | $194K | $180K | $165K | $152K | $893 | $2K | $3K | $1K | $3.23M | $1.15M | $28K | $1K | $0 |
| Deferred Income Tax | $1.06M | $576K | $576K | $576K | -$167K | $0 | $0 | -$450K | $0 | $844K | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $10.84M | $11.84M | $6.62M | $3.91M | $1.45M | $803K | $716K | $780K | $987K | $732K | $486K | $470K | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $818K | -$818K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | -$12.65M | -$2.13M | $0 | $0 | $0 | $0 | -$818K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $8.77M | $2M | $1.76M | -$112K | -$579K | -$857K | $1.14M | $971K | -$307K | $105K | $453K | $0 | $11K | -$906 | $906 |
| Other Working Capital | $4.94M | -$1.55M | -$5.77M | $351K | -$2.14M | -$10K | $1.06M | -$461K | $422K | $563K | -$90K | $165K | -$709 | $3K | $5K |
| Total Working Capital Change | $1.05M | -$1.69M | -$4.01M | $240K | -$2.72M | -$867K | $2.2M | $510K | $116K | $668K | $363K | $165K | $11K | $2K | $6K |
| Other Non-Cash Items | $27K | $284K | $102K | $378K | $68K | $529K | $212K | $377K | $1.31M | $150K | -$3.56M | -$1.22M | -$28K | -$1K | -$26K |
| Net Cash from Operating | -$26.55M | -$28.2M | -$29.06M | -$28.36M | -$24.25M | -$16.93M | -$12.44M | -$11.32M | -$7.97M | -$5.9M | -$2.39M | -$705K | -$21K | -$20K | -$21K |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$5.75M | $0 | $0 | $0 | -$40.01M | -$2K | $0 | $0 | -$2K | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $256K | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $256K | $0 | $0 | $0 | -$2 | $0 |
| Net Cash from Investing | -$5.75M | -$5M | $0 | $0 | -$40.01M | -$2K | $0 | $0 | -$2K | $256K | $0 | $0 | $0 | -$2 | $0 |
| Financing Activities | |||||||||||||||
| Debt Repaid | - | - | - | - | $173K | -$165K | - | - | - | $600K | - | - | - | - | - |
| Common Stock Issuance | $32.3M | $13.8M | $13.8M | $0 | $89.43M | $15.58M | $11.12M | $16.17M | $6.67M | $5.43M | $1.51M | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$3.83M | $31K | $0 | $31.21M | $7.16M | $23K | $1.13M | $6.67M | -$65K | $0 | $2.26M | $0 | $0 | $27K |
| Net Cash from Financing | $33.3M | $9.97M | $13.83M | $0 | $120.47M | $22.9M | $11.15M | $17.3M | $10.88M | $5.26M | $1.51M | $2.26M | $20K | $20K | $18K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1M | -$23.23M | -$15.23M | -$28.36M | $56.21M | $5.97M | -$1.29M | $5.98M | $2.91M | -$382K | -$876K | $1.55M | $54K | -$77 | -$2K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$26.55M | -$28.2M | -$29.06M | -$28.36M | -$24.25M | -$16.93M | -$12.44M | -$11.32M | -$7.97M | -$5.9M | -$2.39M | -$705K | -$21K | -$20K | -$21K |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$40.01M | -$2K | $0 | $0 | -$2K | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$26.55M | -$28.2M | -$29.06M | -$28.36M | -$64.26M | -$16.93M | -$12.44M | -$11.32M | -$7.97M | -$5.9M | -$2.39M | -$705K | -$21K | -$20K | -$21K |
| Cash at Beginning | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.2M | $294K | $676K | $1.55M | $54K | $135 | $212 | $3K |
| Cash at End | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M | $7.89M | $9.18M | $3.2M | $294K | $676K | $1.61M | $54K | $135 | $212 |